Featured Research

from universities, journals, and other organizations

Malaria during pregnancy: New study assesses risks during first trimester

Date:
December 16, 2011
Source:
Wellcome Trust
Summary:
The largest ever study to assess the effects of malaria and its treatment in the first trimester of pregnancy has shown that the disease significantly increases the risk of miscarriage, but that treating with antimalarial drugs is relatively safe and reduces this risk.

The largest ever study to assess the effects of malaria and its treatment in the first trimester of pregnancy has shown that the disease significantly increases the risk of miscarriage but that treating with antimalarial drugs is relatively safe and reduces this risk.

Related Articles


In the study, carried out at the Shoklo Malaria Research Unit (SMRU) in Thailand and funded by the Wellcome Trust, researchers examined medical records of women attending the unit's antenatal clinic over the 25 years since it was founded.

Malaria kills around one million people each year, mainly children and pregnant women. Malaria in pregnancy is a major cause of maternal mortality and of low birth weight, which predisposes to neonatal mortality.

The disease is caused by infection with the malaria parasite. Two major species -- Plasmodium falciparum and Plasmodium vivax -- commonly infect pregnant women in the South-east Asia region. The parasites are transmitted into the blood stream through the bite of infected mosquitos. They proceed to enter the liver, where they multiply, before leaving and infecting red blood cells. P. vivax is able to re-emerge from the liver stage, which cannot be treated in pregnancy.

The most effective drug for treating malaria is artemisinin, which is usually given as part of a combination therapy (a cocktail of drugs intended to treat the disease while reducing the risk of the emergence of parasites resistant to one particular drug). Artemisinin combination therapies (ACT) are recommended by the World Health Organization for the treatment of malaria except in the first trimester. This is because animal studies have indicated that the drugs can be toxic to embryos.

Despite the risks to pregnant women, there is very little published evidence on the effects of malaria and antimalarial drug exposure during the first trimester of pregnancy. This is in part because antenatal clinic services are often unavailable in the rural tropics and if they are, women rarely attend the clinics before their second trimester.

In addition, pregnant women are usually excluded from clinical trials of new drugs because of the risks of adverse effects; no randomised controlled trial has ever been carried out on how best to treat malaria in the first trimester.

In a study published recently in the journal Lancet Infectious Diseases, researchers at the SMRU, part of the Wellcome Trust-Mahidol University-Oxford University Tropical Medicine Research Programme, examined the records of all women attending antenatal clinics at the unit. Of these, 16 668 had no malaria during pregnancy, and 945 had only a single episode during their first trimester and no episodes later in pregnancy.

Around one in five pregnancies resulted in miscarriage when malaria was not a factor. Symptomatic malaria increased the risk of miscarriage to one in two pregnancies; for asymptomatic malaria, the risk of miscarriage was one in three pregnancies.

In women with malaria, more severe disease, higher levels of parasites in the blood and infection at an earlier stage of pregnancy increased the risk of miscarriage further. The risks associated with miscarriage were similar for P. falciparum and P. vivax infections.

P. falciparum infections were treated with quinine or artesunate, or inadvertently with ACT, and P. vivax infections were treated with chloroquine. Of the women treated (irrespective of symptoms), 26 per cent miscarried after chloroquine, 27 per cent after quinine and 31 per cent after artesunate. After inadvertent treatment with an ACT, the miscarriage rate was 24 per cent, comparable to the rate associated with other treatments.

"Malaria is a potentially deadly disease and is particularly dangerous during pregnancy, both to the health of the mother and to the health of her unborn child," explains Dr Rose McGready from the Shoklo Malaria Research Unit. "Understanding the risks is essential for weighing up the treatment options.

"Our work has highlighted the particular risk factors with malaria infection during pregnancy. Particularly worrying is the risk of miscarriage even when the disease is asymptomatic. However, while the dangers of miscarriage are considerable, our study offers some good news: that the most common drugs reduce this risk significantly."

Combating infectious diseases is one the strategic priorities of the Wellcome Trust. Much of this work is carried out at a local level in regions where disease is endemic. This includes several major overseas programmes, including the Wellcome Trust-Mahidol University-Oxford University Tropical Medicine Research Programme.

Dr Jimmy Whitworth, Head of International Activities at the Wellcome Trust, says: "This is a very important observational study on the risks of treating malaria in women in early pregnancy, a key high-risk group for this infection. These results, which come from the research group that has done the majority of studies of malaria in pregnancy anywhere in the world, show that antimalarial treatment with standard first-line drugs reduces the risk of miscarriage in the first trimester. These findings are likely to change practice guidelines worldwide and to save the lives of many women and unborn children."


Story Source:

The above story is based on materials provided by Wellcome Trust. Note: Materials may be edited for content and length.


Journal Reference:

  1. R McGready, SJ Lee, J Wiladphaingern, EA Ashley, MJ Rijken, M Boel, JA Simpson, MK Paw, M Pimanpanarak, Oh Mu, P Singhasivanon, NJ White, FH Nosten. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. The Lancet Infectious Diseases, 2011; DOI: 10.1016/S1473-3099(11)70339-5

Cite This Page:

Wellcome Trust. "Malaria during pregnancy: New study assesses risks during first trimester." ScienceDaily. ScienceDaily, 16 December 2011. <www.sciencedaily.com/releases/2011/12/111212220956.htm>.
Wellcome Trust. (2011, December 16). Malaria during pregnancy: New study assesses risks during first trimester. ScienceDaily. Retrieved December 27, 2014 from www.sciencedaily.com/releases/2011/12/111212220956.htm
Wellcome Trust. "Malaria during pregnancy: New study assesses risks during first trimester." ScienceDaily. www.sciencedaily.com/releases/2011/12/111212220956.htm (accessed December 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, December 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Healthier Lifestyles Could Prevent 4 In 10 Cancer Cases

Healthier Lifestyles Could Prevent 4 In 10 Cancer Cases

Newsy (Dec. 26, 2014) If patients had led healthier lifestyles, Cancer Research UK found about 40 percent of cancer cases could have been prevented. Video provided by Newsy
Powered by NewsLook.com
When Healthy Eating Becomes Dangerous

When Healthy Eating Becomes Dangerous

Newsy (Dec. 26, 2014) Experts say fad diets can lead to orthorexia, a disorder that can cause physical and emotional distress. Video provided by Newsy
Powered by NewsLook.com
FDA Issues New Warning About Pure Caffeine Powder Usage

FDA Issues New Warning About Pure Caffeine Powder Usage

Newsy (Dec. 24, 2014) The FDA cites two deaths this year linked to pure caffeine powder as warnings of the potentially fatal substance. Video provided by Newsy
Powered by NewsLook.com
Alarming CDC Lab Report Reveals Ebola Sample Mix-Up

Alarming CDC Lab Report Reveals Ebola Sample Mix-Up

Newsy (Dec. 24, 2014) The Centers for Disease Control and Prevention released a report claiming a lab tech in Atlanta might have been exposed to the Ebola virus. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins